Anupam Rasayan IPO subscribed 1.29 times on first day

The Rs 760-crore Anupam Rasayan IPO received bids for 1,25,08,209 shares against 97,01,809 shares on offer, according to NSE data

Krsnaa Diagnostics' initial public offer comprises a fresh issue of up to Rs 400 crore and an offer for sale of up to 85,25,520 equity shares.

New Delhi:  The initial public offer of speciality chemicals company Anupam Rasayan India Limited was subscribed 1.29 times on the first day of subscription on March 12.

The Rs 760-crore public issue received bids for 1,25,08,209 shares against 97,01,809 shares on offer, according to NSE data.

The category for non-institutional investors was subscribed 9% and those for retail individual investors (RIIs) 2.58 times.

Price range for the offer, which would close on Tuesday, has been fixed at Rs 553-555 per share.

Anupam Rasayan had on March 10 raised Rs 225 crore from anchor investors. The initial public offer (IPO) is an entirely fresh issuance of equity shares and proceeds of the issue would be mainly used to pay the debt.

Axis Capital, Ambit Private Limited, IIFL Securities Limited and JM Financial Limited are the managers to the offer.

Anupam Rasayan commenced operations in 1984 with conventional products and now it makes speciality chemicals that involve multi-step synthesis and complex chemistries.

The company mainly caters to the agrochemical, personal care and pharmaceutical sectors, which accounted for over 95% of its revenues in 2019-20.  Its clients include Syngenta Asia Pacific, Sumitomo Chemical Company and UPL Limited.

Published: March 12, 2021, 19:33 IST
Exit mobile version